4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001641172-25-014692
Options or other derivatives
- Director acquired 12,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Karah Hila Director | 2025-06-10 | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | D | ||
Loading xslF345X05/ownership.xml…